Journal
LANCET REGIONAL HEALTH-EUROPE
Volume 28, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.lanepe.2023.100595
Keywords
SARS-CoV-2; Post-COVID condition; 2-Year follow-up; Residual symtoms; Rehabilitation; COVID-19; Long-term; Longitudinal
Ask authors/readers for more resources
This study is one of the first to report long-term recovery outcomes in patients with post-COVID-19 condition (PCC) following hospitalization. The study found that over 40% of patients still experienced persisting symptoms and limitations in daily life four months after discharge. A follow-up at 24 months showed a high prevalence of persisting symptoms and a need for long-term follow-up and rehabilitation post COVID-19 infection.
Background Few studies have reported the long-term health effects of COVID-19. The regional population-based Linkoping COVID-19 study (LinCoS) included all patients hospitalised due to COVID-19 during the first pandemic wave. Four months post-discharge, over 40% (185/433) experienced persisting symptoms and activity/ participation limitations, indicating post-COVID-19 condition (PCC). The present follow-up study aimed to determine the long-term recovery among these patients 24 months post-admission.Methods This prospective cohort study included all patients from LinCoS with PCC at four months post-discharge. We repeated the same structured interview at a 24-month follow-up to identify persisting symptoms and their impact on daily life. Intercurrent health issues were identified by reviewing medical records.Findings Of 185 patients with PCC at 4 months post-discharge, 181 were alive at the 24-month assessment and 165 agreed to participate. Of those, 21% (35/165) had been readmitted to hospital for various causes in the interim period. The majority of patients (139/165, 84%) reported persisting problems affecting everyday life at 24 months. Significant improvements were seen in the prevalence and magnitude of some symptoms/limitations compared with four months post-discharge. Cognitive, sensorimotor, and fatigue symptoms were the most common persisting symptoms at 24 months. No clear difference was evident between individuals treated in the intensive care unit (ICU) and non-ICU-treated individuals. Approximately half of those who were on sick leave related to PCC at four months after infection were on sick leave at 24 months.Interpretation This is one of the first studies to report 2-year outcomes in patients with PCC following COVID-19 hospitalisation. Despite some improvements over time, we found a high prevalence of persisting symptoms and a need for long-term follow-up and rehabilitation post COVID-19 infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available